Clinical pathway for patients with Chronic Myeloid Leukaemia: The Euriclea Project

Background and aims: The use of Tirosine Kinase Ihnibitors (TKIs) for the treatment of Chronic Myeloid Leukemia (CML) has definitely represented a turning point in the treatment of the onco-hematological diseases. Over the years, the interest of physicians, nurses, patients and caregivers has increa...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Acta Biomed
Main Authors: Botti, Stefano, Gargiulo, Gianpaolo, Bombaci, Felice, Artioli, Giovanna, Cosentino, Chiara, Pignatelli, Adriana Concetta, Torino, Daniela, Lionetti, Maria Marcella, Samarani, Emanuela, Cappucciati, Lorella, Bordiga, Paola, Diodati, Antonella, Caffarri, Cristiana, Rosini, Irene, Pane, Fabrizio
פורמט: Artigo
שפה:Inglês
יצא לאור: Mattioli 1885 2017
נושאים:
Original Article: On the Patient's: Focus on Leukaemia
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC6357587/
https://ncbi.nlm.nih.gov/pubmed/28752827
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.23750/abm.v88i3-S.6608
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים